??????????2034????108?5400???????????

?????????????2024??22?7000??????????2034?????108?5400?????????????????2025???2034????????????CAGR?16.93????????????????????????????????????????????????????????????????? ???????????????????????????????????CAGR??????????????

????????????

2024????????????????
???????????????????????????????????
?????????????????????????
????????????????????????????????2025???2034?????????????CAGR???????????????

??????????

????	??
2025??????	25?9200????
2034????????	10,854?????
2025???2034?????????	???????CAGR?16.93%

????????????????????????????????????????????????????????????????????????DNA??????????????????????????????????????????????????????????????????????????????????????????????????? ????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????

?????????????

?????32?????????????????????????????
2024??1???????????????CT-053?CARsgen?????????B?????????????????????????
????????????2,093??CAR-T???????????????????????????????RNA????????????52%?????
?????????????????????????????4????????43%??????????????????????????????????

AI???????????

?????AI????????????????????????????????????????????????AI????????????????????????????????????????????????????????????????????????? ???????????????????????????????????????????????????????????????????????????????????????????????AI???????AI???????????????????????????????????????????????????????????????

?????????????????????

?????????????????CRISPR-Cas9?????????????????????????????????????????????????????????????????

????????

CRISPR-Cas9?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ??????COVID-19???????????????????????????????????????????????????????????????????????????COVID-19?????????????????????????????????????????mRNA-1273??COVID-19??????94.5%?????????????

??

???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????

??????????????????

???????????????????????????????????????????????????????????????????

????????

???????????????????????????????????????????????????????????FDA????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????

????????

?????????????

???????????????????????????????????????????????????????????????????????????????????????????????????

2025?3??????????????????????????????????????????????????????????????????????????III??????????????????????????????????????????????????????????????????????

????

??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????

?????

??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ????CRISPR?AI?????????????????????????????????????????????????????????????????????????????????????????????????????

???????????

???????????????????????????????????????

?????????????????????????????????1??????????????????????????

????????????????????????? EB ??????????????????????????

????????????????????????????????????????????????????????

???????????????????

??????

????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????

????????

???????????????????

2024???????????????????????????????????????FDA???????????????????????????????????????????????????????????????????????????????????????????????????????CMO??????????????????????? ??????????????????????????????????????2025?6???????????FDA???AAVrh.74??????????RP-A701????????????????FDA????????????????????????????????????????BAG3?????????BAG3-DCM??????????????

??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? ????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????

?????????????????

2025?6???????????????????????????????HIV?????????????????????????????????????????AST?????????????????????????????????????????????????
2025?5????????????????????????????????????4??500????????????????????????????Part the Cloud??????????????????Translational Gene Targeting Challenge???????

?????

????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????

??????????
????1978?
?????????????????????

???????2024?12?31???????????96?7600?????2023??1.62%??????

??????????
????1996?
??????????????

???????2024???????517?2200?????2023??????10.85%???????2023????????466?6000?????2022???7.36%???????

??????????????
????1992?
??????????????????????

???????????2023???????2,950?????????????ZYNTEGLO???SKYSONA?????????

発行元 Rohan Patil

グローバル市場 Statistics

Last Updated: 01 Jul 2025

Source: Statifacts

Last Updated: 01 Jul 2025

Source: Statifacts

Gene Therapy Market Revenue, By Sub-segments, 2024 to 2034 (USD Million)

Subsegment	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Gene Augmentation	2,896.10	3,331.70	3,852.80	4,482.10	5,250.00	6,186.10	7,319.90	8,697.70	10,386.90	12,434.90	14,855.10
Gene Editing	1,664.70	1,910.70	2,204.50	2,558.90	2,990.70	3,516.10	4,151.40	4,922.00	5,865.20	7,006.60	8,352.40
Oncolytic Viral Therapy	885.60	1,006.60	1,150.00	1,321.60	1,529.30	1,780.00	2,080.40	2,441.60	2,879.80	3,404.90	4,016.90
RNA-Based Therapy	654.00	737.40	835.60	952.40	1,092.70	1,260.90	1,460.80	1,699.00	1,985.60	2,325.60	2,717.20

Last Updated: 01 Jul 2025

Source: Statifacts

参考文献

Primary Research Interviews

Stakeholders: Gene therapy developers, clinicians, regulatory bodies, key opinion leaders (KOLs), and researchers in gene therapy.
Databases: PubMed, ClinicalTrials.gov, Gene Therapy Clinical Trials Database.

Magazines

GEN (Genetic Engineering & Biotechnology News)
BioTechniques
Pharmaceutical Technology

Journals

Molecular Therapy
Gene Therapy (Nature Publishing Group)
The Journal of Gene Medicine
Human Gene Therapy

Newspapers

The Wall Street Journal (for industry news on biotechnology and pharmaceutical sectors)
The Financial Times (business-related insights on the pharmaceutical industry)

Associations

American Society of Gene & Cell Therapy (ASGCT)
European Society of Gene and Cell Therapy (ESGCT)
International Society for Cell & Gene Therapy (ISCT)

Public Domain Sources

U.S. Food and Drug Administration (FDA)
European Medicines Agency (EMA)
World Health Organization (WHO)

Proprietary Elements

Clinical trial data from proprietary databases such as Informa, Evaluate Pharma, and Frost & Sullivan.
Market reports from leading market research firms (e.g., Grand View Research, Market Research Future).

グローバル Market Statistics

Gene Therapy Market Driven by Technological and Lifestyle Shifts 収益, By Therapy Type 2024年から2034年（百万米ドル）

サブセグメント	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Gene Augmentation	2,896.10	3,331.70	3,852.80	4,482.10	5250	6,186.10	7,319.90	8,697.70	10,386.90	12,434.90	14,855.10
Gene Editing	1,664.70	1,910.70	2,204.50	2,558.90	2,990.70	3,516.10	4,151.40	4922	5,865.20	7,006.60	8,352.40
Oncolytic Viral Therapy	885.60	1,006.60	1150	1,321.60	1,529.30	1780	2,080.40	2,441.60	2,879.80	3,404.90	4,016.90
RNA-Based Therapy	654	737.40	835.60	952.40	1,092.70	1,260.90	1,460.80	1699	1,985.60	2,325.60	2,717.20

PDFをダウンロード

Frequently Asked Questions

Gene therapy is a broad term for a number of biotechnological and therapeutic approaches that modify or replace faulty genes to treat or prevent disease. It uses vectors, often viruses, to deliver genetic material into a patient�s cells to correct underlying genetic disorders

Gene therapy is being developed for conditions like inherited genetic disorders, certain cancers, and rare diseases such as spinal muscular atrophy, hemophilia, and retinal diseases.

The market is expanding due to advancements in genetic engineering, increasing approvals of gene-based drugs, rising prevalence of rare and chronic diseases, and strong R&D investments.

High treatment costs, complex regulatory approvals, manufacturing scalability, and long-term safety concerns remain key hurdles to widespread adoption.

Who are the leading players in the market? Major players include Novartis, Spark Therapeutics, Sarepta Therapeutics, BioMarin Pharmaceutical, and Bluebird Bio, all of which are developing and commercializing gene-based treatments globally.

??????????2034????108?5400???????????

????????????

??????????

?????????????

AI???????????

?????????????????????

????????

??

??????????????????

????????

????????

?????????????

????

?????

???????????

???????????????????

??????

????????

?????????????????

?????

グローバル市場 Statistics

Gene Therapy Market Revenue, By Sub-segments, 2024 to 2034 (USD Million)

参考文献

Primary Research Interviews

Magazines

Journals

Newspapers

Associations

Public Domain Sources

Proprietary Elements

グローバル Market Statistics

Gene Therapy Market Driven by Technological and Lifestyle Shifts 収益, By Therapy Type 2024年から2034年（百万米ドル）

Frequently Asked Questions

購入手続きへ進む

カスタマイズされたソリューションをお探しですか？

カスタマイズの50％は当社が負担します。インサイト、トレンド、戦略計画をあなたのニーズに合わせて最適化します。

データブックをダウンロード

パートナー企業

??????????2034????108?5400???????????

????????????

??????????

?????????????

AI???????????

?????????????????????

????????

??

??????????????????

????????

????????

?????????????

????

?????

???????????

???????????????????

??????

????????

?????????????????

?????

グローバル 市場 Statistics

Gene Therapy Market Revenue, By Sub-segments, 2024 to 2034 (USD Million)

参考文献

Primary Research Interviews

Magazines

Journals

Newspapers

Associations

Public Domain Sources

Proprietary Elements

グローバル Market Statistics

Gene Therapy Market Driven by Technological and Lifestyle Shifts 収益, By Therapy Type 2024年から2034年（百万米ドル）

Frequently Asked Questions

What is gene therapy, and how does it work?

What are the key applications of gene therapy?

What is driving the growth of the global gene therapy market?

What are the major challenges in the market?

Who are the leading players in the market?

購入手続きへ進む

カスタマイズされたソリューションをお探しですか？

カスタマイズの50％は当社が負担します。インサイト、トレンド、戦略計画をあなたのニーズに合わせて最適化します。

データブックをダウンロード

グローバル市場 Statistics